Calcium sensing receptors, ligands, compositions, and methods of use
First Claim
Patent Images
1. A method of treating a disease in a subject, the method comprising the step of:
- administering an amount of L-1,2,3,4-tetrahydronorharman-3-carboxylic acid (TNCA) to the subject in need thereof, wherein the subject has a disease associated with a mutation of the extracellular calcium-binding domain (ECD) of a calcium-sensing receptor protein (CaSR) or a disease associated with abnormal CaSR expression or abnormal CaSR activity in a subject in need thereof.
4 Assignments
0 Petitions
Accused Products
Abstract
Described herein are compounds that can bind CaSR and/or a CaSR extracellular domain and formulations thereof. Also described herein are methods of inhibiting CaSR and/or treating a disease or disorder associated with a mutation in CaSR by administering a compound or formulation thereof described herein. Also described herein are assays that can be used to identify compounds that can bind an extracellular domain of CaSR.
3 Citations
16 Claims
-
1. A method of treating a disease in a subject, the method comprising the step of:
administering an amount of L-1,2,3,4-tetrahydronorharman-3-carboxylic acid (TNCA) to the subject in need thereof, wherein the subject has a disease associated with a mutation of the extracellular calcium-binding domain (ECD) of a calcium-sensing receptor protein (CaSR) or a disease associated with abnormal CaSR expression or abnormal CaSR activity in a subject in need thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
9. A method comprising:
-
contacting an extracellular calcium-binding domain (ECD) of a calcium sensing receptor protein (CaSR) with L-1,2,3,4-tetrahydronorharman-3-carboxylic acid (TNCA) and a candidate compound suspected of modulating the activity of the CaSR; and measuring CaSR activity or TNCA binding to the ECD. - View Dependent Claims (10, 11, 12, 13, 14, 15, 16)
-
Specification